NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its ...
The US Food and Drug Administration (FDA) has given the green light for Tiziana Life Sciences’ investigational new drug (IND) to advance its Phase IIa study of intranasal foralumab intended to treat ...
A man with a terminal brain condition says the Government needs to fix the UK’s palliative care system first before legislating assisted dying. Matt Saunders, 49, from Cornwall, was diagnosed with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback